Thermo Fisher Scientific Inc (TMO)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 7,037,000 | 6,298,000 | 7,835,000 | 8,841,000 | 7,225,000 |
| Revenue | US$ in thousands | 42,879,000 | 42,857,000 | 44,915,000 | 39,211,000 | 32,218,000 |
| Pretax margin | 16.41% | 14.70% | 17.44% | 22.55% | 22.43% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $7,037,000K ÷ $42,879,000K
= 16.41%
Thermo Fisher Scientific Inc's pretax margin has shown some fluctuations over the years. The trend indicates stability with a slight increase from 22.43% in December 2020 to 22.55% in December 2021. However, there was a notable decline in pretax margin to 17.44% in December 2022, which further dropped to 14.70% by December 2023. The margin then saw a slight improvement to 16.41% by December 2024.
While the pretax margin has experienced some variability during this period, it is important to consider the underlying reasons for these fluctuations. Management may need to review cost structures, sales strategies, and operational efficiency to maintain or improve profitability levels in the future. Additionally, external factors such as economic conditions and industry competition could have also influenced the company's pretax margin performance.
Peer comparison
Dec 31, 2024